2-N-(4-Aminobutyl)-amino-5-bromopyridine, 97.0%, 1g

Lead(II) acetate trihydrate, min. 99.5%, pa, ACS, ISO, 100 g, plastic packaging.

Methyl 2-(6-bromo-1H-indol-3-yl)acetate, 97%, 1g

Sarafloxacin Hydrochloride, >97.0%(HPLC), 250mg

2-Butyl-4,6-dichloropyrimidine, 250mg

5-Oxo-5-pyrrolidin-1-yl-pentanoic acid, 95+%, 250mg

2-Chloro-4-(pyrrolidin-1-yl)benzoic acid, 95.0%, 250mg

(3-METHYLPIPERIDIN-2-YL)METHANOL, 95.0%, 250mg

5-Bromo-1H-benzimidazole, 97.0%, 1g

Methyl 2-bromoacrylate, 97.0%, 1g

2-Chloro-3-fluoro-5-nitropyridine, 95.0%, 1g

Methyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate, 95.0%, 25g

(R)-2-(4-chlorophenylsulfonamido)-5,5,5-trifluoropentanamide, 98%, 100mg